Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pioglitazone × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 6 Genitourinary 5 Myeloid 4 Thoracic 3 Head & Neck 2 Gastrointestinal 2 Breast 2 Tumor-Agnostic 1 Sarcoma 1 Plasma cell 1 Dermatologic 1 CNS 1

Conditions

Liposarcoma, Myxoid 1 Liposarcoma 1

Interventions

Cyclophosphamide 189 Radiotherapy 185 Doxorubicin 178 Temozolomide 161 Ifosfamide 104 Filgrastim 97 Imatinib Mesylate 88 Etoposide 88 Vincristine 80 Gemcitabine 75 Bevacizumab 71 Irinotecan 69 Magnetic Resonance Spectroscopy 65 pembrolizumab 60 Radiation 58 Carboplatin 55 pazopanib 51 Methotrexate 51 fludarabine phosphate 49 Cisplatin 49 Nivolumab 47 Specimen Handling 46 Peripheral Blood Stem Cell Transplantation 45 Trabectedin 43 Docetaxel 43 Melphalan 42 Busulfan 42 Biopsy 42 Paclitaxel 38 fludarabine 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04794127 2026-02-18

TRABEPIO

Mario Negri Institute for Pharmacological Research

Phase 2 Completed

Liposarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡